Small molecule activates innate immune responses controlled by the human protein STING.

Case ID:
2907
Web Published:
6/30/2020
Description:

Researchers at OHSU have discovered a novel small molecule agonist of human protein STING that may be administered either as an adjuvant to a vaccine or as independent therapy for treatment of infectious disease and/or cancer.

 

Patent Information:
Category(s):
Vaccines
Therapeutics
For Information, Contact:
Travis Cook
Senior Technology Development Manager
Oregon Health & Science University
cooktr@ohsu.edu
Inventors:
Victor DeFilippis
Jinu Abraham
Sara Botto
Keywords:
Therapeutics
Therapeutics - Cancer
Therapeutics - Immunology
Therapeutics - Infectious Diseases
© 2020. All Rights Reserved. Powered by Inteum